Tracking tolerability on tirzepatide during titration

I have been logging tolerability through the standard titration schedule for tirzepatide, mostly to understand how much the gastrointestinal effects track with each step up. The nausea has been very dose-step dependent in my own log, easing after the first week at each level.

Curious how this matches other peoples logs. I am specifically interested in whether slower titration meaningfully reduced side effects for you, since the trials suggest the gradual ramp exists precisely for tolerability.